KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 105 filers reported holding KURA ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $560,000 | -25.6% | 17,158 | -30.2% | 0.00% | -33.3% |
Q3 2020 | $753,000 | +151.0% | 24,576 | +33.6% | 0.00% | +50.0% |
Q2 2020 | $300,000 | +120.6% | 18,397 | +34.2% | 0.00% | +100.0% |
Q1 2020 | $136,000 | -90.7% | 13,710 | -87.1% | 0.00% | -80.0% |
Q4 2019 | $1,457,000 | -62.1% | 105,939 | -58.2% | 0.01% | -64.3% |
Q3 2019 | $3,844,000 | -34.0% | 253,385 | -14.4% | 0.01% | -33.3% |
Q2 2019 | $5,827,000 | +261.9% | 295,927 | +204.9% | 0.02% | +250.0% |
Q1 2019 | $1,610,000 | – | 97,057 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |